Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001532218-26-000004

CHAIRMAN & CEO sold 7,278 shares at $50.01 ($363,973)

  • CHAIRMAN & CEO gave up 4,831 shares (to pay taxes)
  • CHAIRMAN & CEO acquired 17,269 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Sanj K · CHAIRMAN & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +7,278 $10.36 $75,400 7,278 D
2026-04-06 Sale : show line 2 in the form 10b5-1 −7,278 $50.01 $363,973 0 D
2026-04-07 Exercise or conversion : show line 3 in the form 10b5-1 +9,991 81,005 I
2026-04-07 Shares withheld for taxes : show line 4 in the form 10b5-1 −4,831 $48.94 $236,429 76,174 I
Open-market sales · 7,278 sh · avg $50.01 · $363,973

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-06 Exercise or conversion : show line 5 in the form 10b5-1 Share Option −7,278 431,904 D
2026-04-07 Exercise or conversion : show line 6 in the form 10b5-1 Restricted Share Unit −9,991 0 D
Loading xslF345X06/form4-04082026_080403.xml…